Heart Disease News and Research

Latest Heart Disease News and Research

Brazilian cardiovascular researcher receives Georg Forster Research Award

The cardiovascular researcher Professor Robson Augusto Souza dos Santos of the Federal University of Minas Gerais in Belo Horizonte, Brazil, has been awarded the Georg Forster Research Award of the Alexander von Humboldt Foundation.

28 Jul 2015

New Iowa State study finds strong link between insulin resistance and increased Alzheimer's disease risk

The fact that obesity increases the risk of cardiovascular disease and some cancers is well known. But a new Iowa State University study adds to the growing evidence that memory loss should also be a top concern.

28 Jul 2015

Scientists reveal potential therapeutic approach to idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis is a very aggressive form of pulmonary fibrosis and has a particularly poor prognosis. This fatal disease, for which so far no causal therapies exist, is characterized by a massive deposition of connective and scar tissue in the lung, which leads to a progressive loss of lung function and ultimately death.

28 Jul 2015

TSRI scientists awarded grant to explore therapeutic potential of protein receptors in Parkinson's disease, other disorders

Scientists from the Florida campus of The Scripps Research Institute have been awarded nearly $1.5 million from the National Institute of General Medical Sciences of the National Institutes of Health to explore the therapeutic potential of a class of proteins that play essential roles in the regulation and maintenance of human health.

28 Jul 2015

Research findings may provide new approach to treating male infertility

A team of researchers from the National University of Singapore's (NUS) Yong Loo Lin School of Medicine has demonstrated for the first time that hydrogen sulphide (H2S), when applied exogenously, could protect testicular germ cells, which are male reproductive cells, against heat-induced injury, which is one of the major causes of male infertility.

28 Jul 2015

Low-dose lithium lowers involuntary motor movements in mouse model of Parkinson's disease

Low-dose lithium reduced involuntary motor movements - the troubling side effect of the medication most commonly used to treat Parkinson's disease (PD) - in a mouse model of the condition that is diagnosed in about 60,000 Americans each year. The third in a series of studies from the Andersen lab involving PD and low-dose lithium, the results add to mounting evidence that low-doses of the psychotropic drug could benefit patients suffering from the incurable, degenerative condition.

28 Jul 2015

RE.WORK Future Technology Summit to showcase breakthrough technologies in MedTech

New technology is changing the way we work and live. At the third annual RE.WORK Future Technology Summit we will showcase breakthrough technologies in Robotics, Artificial Intelligence, MedTech, 3D Printing, Smart Materials , IoT, and Wearable Technology to explore their impact on business, society and the home.

27 Jul 2015

UMass Amherst toxicologist hopes US regulatory agency may acknowledge hormesis hypothesis soon

When environmental toxicologist Edward Calabrese in the School of Public Health and Health Sciences at the University of Massachusetts Amherst heard recently that the U.S. National Regulatory Commission has opened a new docket on proposed rule changes and standards for radiation protection, he felt it as "a vindication of my 30-year career, in many ways."

25 Jul 2015

American College of Surgeons calls for meaningful data sharing for improved patient care

The American College of Surgeons strongly believes that patients and their families deserve to have meaningful information available to assist them in selecting the right surgeon.

25 Jul 2015

Researchers discover first fully synthetic substrate with potential to grow billions of stem cells

If you experience a major heart attack the damage could cost you around five billion heart cells. Future stem cell treatments will require this number and more to ensure those cells are replaced and improve your chances of survival.

25 Jul 2015

Rutgers physicians use new treatments to restore teenager’s life

At first, 13-year-old Christina Blumstein thought she had an ordinary headache. She and her parents were returning from a visit to Long Island in July 2014 when the pain struck. Was it a bout of carsickness? Too much screen time on her iPad? But a few hours later, back home in Old Bridge, New Jersey, her mother MaryAnn says, "Christina started screaming that somebody was stabbing her in the head with a knife." Soon afterward Christina was comatose and in an ambulance - and her life was in grave danger.

25 Jul 2015

Abbott, BMW BERLIN-MARATHON partner to celebrate the power of health

The organizers of the BMW BERLIN-MARATHON today proudly announced a new partnership with the global healthcare company Abbott, which became an Official Sponsor of the 2015 BMW BERLIN-MARATHON, one of six iconic races in the Abbott World Marathon Majors series.

25 Jul 2015

First holography scanning device significantly reduces denture-fitting time

Dentures, known as false teeth, are prosthetics constructed to replace missing teeth. Fitting removable dentures is a long and painful process in which a patient has to visit the clinic multiple times so that soft and hard plastic material, resembling silly putty, can be used to take exact measurements of her mouth.

25 Jul 2015

Ben Taub Hospital building national reputation for cardiovascular services

For most of the day, Graciela Del Angel felt shortness of breath and a tightness in her chest. Though her symptoms were uncomfortable, they became unbearable about midnight. By then, she had difficulty breathing and deep chest pains—all signs of a heart attack.

25 Jul 2015

NEJM suggests use of HCV-positive kidneys as one solution to kidney shortage

The average wait time for a kidney transplant is five years and there are more than 100,000 people on the waiting list. However, there are thousands of viable hepatitis C-positive kidneys that are discarded each year solely because they're infected.

25 Jul 2015

Higher case volume linked with improved outcomes for catheter-based blood clot removal in LE-DVT patients

Patients who have lower extremity proximal deep vein thrombosis (LE-DVT), or a blood clot in their leg, are increasingly undergoing minimally invasive catheter-based blood clot removal - also referred to as catheter-directed thrombolysis (CDT) - rather than solely being treated with traditional blood-thinning medications (anticoagulation alone).

25 Jul 2015

Corgenix Medical to present several scientific abstracts at 2015 AACC Clinical Lab Expo

Corgenix Medical Corporation, the U.S. - based operation of ORGENTEC Diagnostika, is presenting several scientific abstracts at the 2015 American Association for Clinical Chemistry Clinical Lab Expo in Atlanta. Three abstracts involve the ReEBOV Ebola rapid diagnostic test (RDT) with a fourth abstract involving the AtherOx™ Assay for assessing heart disease risk.

25 Jul 2015

WWP's Physical Health and Wellness Program hosts wounded veterans for fitness and nutrition seminar

The Wounded Warrior Project Physical Health and Wellness Program hosted a group of wounded veterans for a full-day fitness and nutrition seminar at Revolution Fitness in New Orleans, Louisiana. Revolution Fitness is an elite athletic training facility that combines functional training tools and innovative programs to ensure optimal physical performance.

25 Jul 2015

Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

Novartis today announced the US Food and Drug Administration has approved Odomzo (sonidegib, formerly LDE225) 200 mg capsules for the treatment of adult patients with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy.

25 Jul 2015

FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration approved Praluent (alirocumab) Injection, the first FDA-approved treatment in a new class of drugs known as PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors.

25 Jul 2015

Heart Disease News and Research

Latest Heart Disease News and Research

Brazilian cardiovascular researcher receives Georg Forster Research Award

New Iowa State study finds strong link between insulin resistance and increased Alzheimer's disease risk

Scientists reveal potential therapeutic approach to idiopathic pulmonary fibrosis

TSRI scientists awarded grant to explore therapeutic potential of protein receptors in Parkinson's disease, other disorders

Research findings may provide new approach to treating male infertility

Low-dose lithium lowers involuntary motor movements in mouse model of Parkinson's disease

RE.WORK Future Technology Summit to showcase breakthrough technologies in MedTech

UMass Amherst toxicologist hopes US regulatory agency may acknowledge hormesis hypothesis soon

American College of Surgeons calls for meaningful data sharing for improved patient care

Researchers discover first fully synthetic substrate with potential to grow billions of stem cells

Rutgers physicians use new treatments to restore teenager’s life

Abbott, BMW BERLIN-MARATHON partner to celebrate the power of health

First holography scanning device significantly reduces denture-fitting time

Ben Taub Hospital building national reputation for cardiovascular services

NEJM suggests use of HCV-positive kidneys as one solution to kidney shortage

Higher case volume linked with improved outcomes for catheter-based blood clot removal in LE-DVT patients

Corgenix Medical to present several scientific abstracts at 2015 AACC Clinical Lab Expo

WWP's Physical Health and Wellness Program hosts wounded veterans for fitness and nutrition seminar

Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

FDA approves Praluent (alirocumab) Injection for treatment of patients with high LDL cholesterol

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Heart Disease News and Research

Latest Heart Disease News and Research

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in